Global firm sets path for continued growth
Penn Pharma, the specialist provider of pharmaceutical development and manufacturing services, is further driving the expansion of its UK operations with a strategic appointment to its Executive Team of Jerome Detreille as Senior Director of New Business Development.
Jerome’s appointment comes after Penn Pharma recently announced a £14 million investment in its South Wales, UK facility to expand its specialist high containment facilities. Jerome’s role will be integral to the success of the new facility, due to open in January 2013.
Jerome joins Penn from Catalent Pharma Solutions where he headed up a European Sales and Business Development team. He brings with him 13 years experience in selling services for conventional and highly potent drugs covering all dosage forms, from oral solid dose to sterile injectables.
Speaking on his appointment, Jerome said: “I am fortunate to have joined such a dynamic business at a significant point in the company’s development. The expansion of our High Containment Operations will give us competitive advantage in the provision of highly potent development and contract manufacturing. I am looking forward to using my experience in negotiating large and complex deals to secure contracts for our expanded unit and hence drive growth for Penn.’’
The construction of the new 15,000 sq ft development and commercial manufacturing unit for tablets and capsules has already commenced and it is designed to meet the highest international Quality Standards. The new facility will enable the team at Penn to further build upon its established 15 year expertise in the manufacture of highly potent drugs for the worldwide market.
Chief Executive, Dr Richard Yarwood believes that Penn staff are key to the company’s continued success. He said: “We are delighted to welcome Jerome to the business development team. He has an outstanding track record and has already made a positive contribution to the team.
“We aim to employ high calibre experienced professionals at Penn in order to deliver excellent service to our clients and this new appointment is going to help us meet that objective.”
Penn Pharma has a wealth of experience in successfully providing an integrated range of services for the development, manufacture and distribution of medicinal products to the global pharmaceutical market.
For more information visit www.pennpharm.com